Bioinformatics Analysis for Circulating Cell-Free DNA in Cancer

Area of Science:

• Molecular biology
• Genomics
• Bioinformatics

Background:

• Cell-free DNA (cfDNA) in body fluids enables non-invasive cancer detection and monitoring via liquid biopsy.
• Advancements in sequencing technologies enhance the study of cfDNA for cancer development and progression.
• Genetic and epigenetic alterations in cfDNA serve as potential diagnostic and prognostic biomarkers across cancer types.

Purpose of the Study:

• To review the molecular characteristics of cancer cfDNA.
• To discuss bioinformatics approaches for analyzing cfDNA sequencing data.
• To highlight challenges and perspectives in cfDNA analysis for clinical application.

Main Methods:

• Review of current literature on cfDNA molecular characteristics.
• Analysis of bioinformatics methodologies for cfDNA sequencing data.
• Identification of challenges in sensitivity and statistical robustness.

Main Results:

• cfDNA analysis reveals genetic mutations, copy number alterations, methylation changes, and nucleosome positioning variations.
• Bioinformatics tools are crucial for interpreting complex cfDNA sequencing data.
• Sensitivity and statistical robustness remain key challenges in cfDNA analysis.

Conclusions:

• cfDNA liquid biopsy is a promising tool for non-invasive cancer screening and monitoring.
• Standardized and advanced bioinformatics analysis is essential for clinical translation.
• Further development is needed to overcome current challenges and integrate cfDNA analysis into clinical practice.